Literature DB >> 8458688

Unusual cleavage of peptidic hormones generated by trypanosome enzymes released in infested rat serum.

D Tetaert1, B Soudan, G Huet-Duvillier, P Degand, A Boersma.   

Abstract

Gonad and thyroid dysfunctions are often observed in human and experimental models during african trypanosomiasis. The enzymatic activity of components released by the trypanosomes towards peptide hormones (e.g. GnRH, TRH) have consequently been studied. The incubation products of GnRH by (i) healthy or infested rat serum: (ii) trypanosomal components released by using a specific procedure; (iii) infested and normal rat brain extracts have been analysed by RP-HPLC fractionation. The peptide cleavage has been assessed by determination of either the amino acid compositions or relative molecular weight (by FAB mass spectrometry) of the different resolved HPLC fractions. Different protease inhibitors and a reducing agent have also been tested and a serine, cation-sensitive, thiol-dependent endopeptidase activity has been predominantly identified to be released by the trypanosomes in host circulation. It has been shown that the peptidase activity(ies) is(are) able to: (i) degrade the peptide hormones (GnRH, TRH) considered as important neuromodulators and neurotransmitters; (ii) generate an unusual N-terminal tetrapeptide (GnRH1-4) appearing to be still active towards the gonadal hypothalamo-pituitary axis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8458688     DOI: 10.1111/j.1399-3011.1993.tb00125.x

Source DB:  PubMed          Journal:  Int J Pept Protein Res        ISSN: 0367-8377


  5 in total

1.  Trypanosome-derived oligopeptidase B is released into the plasma of infected rodents, where it persists and retains full catalytic activity.

Authors:  R E Morty; J D Lonsdale-Eccles; R Mentele; E A Auerswald; T H Coetzer
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Pyroglutamyl peptidase type I from Trypanosoma brucei: a new virulence factor from African trypanosomes that de-blocks regulatory peptides in the plasma of infected hosts.

Authors:  Rory E Morty; Patrick Bulau; Roger Pellé; Sherwin Wilk; Koji Abe
Journal:  Biochem J       Date:  2006-03-15       Impact factor: 3.857

3.  Expression, purification and preliminary crystallographic analysis of oligopeptidase B from Trypanosoma brucei.

Authors:  Dean Rea; Carole Hazell; Norma W Andrews; Rory E Morty; Vilmos Fülöp
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-07-25

Review 4.  Parasite prolyl oligopeptidases and the challenge of designing chemotherapeuticals for Chagas disease, leishmaniasis and African trypanosomiasis.

Authors:  I M D Bastos; F N Motta; P Grellier; J M Santana
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

5.  Prolyl Oligopeptidase From Leishmania infantum: Biochemical Characterization and Involvement in Macrophage Infection.

Authors:  Camila Lasse; Clênia S Azevedo; Carla N de Araújo; Flávia N Motta; Milene A Andrade; Amanda Pereira Rocha; Iracyara Sampaio; Sébastien Charneau; Marc Gèze; Philippe Grellier; Jaime M Santana; Izabela M D Bastos
Journal:  Front Microbiol       Date:  2020-05-28       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.